Vaping Health Risks: Harmful Lung Metals and Cancer Links

E-cigarette devices may deliver harmful metals into users’ lungs, according to a recent study cited by Xinhua News Agency, raising concerns about the long-term respiratory risks associated with vaping.

The study, referenced in the Xinhua report, found that e-cigarette devices can release toxic metals such as lead, nickel, and chromium into the aerosol inhaled by users. These metals originate from the heating coils and other internal components of the devices, particularly when the devices are used at high power settings or with low-quality materials.

Inhalation of these metals poses a direct threat to lung tissue, as they can cause inflammation, oxidative stress, and cellular damage. Over time, such exposure may contribute to chronic respiratory conditions, including reduced lung function and increased susceptibility to infections.

These findings align with broader scientific concerns about the health impacts of e-cigarettes. Research from the American Lung Association and the National Academies of Science, Engineering, and Medicine has consistently shown that e-cigarette aerosols contain harmful substances, including volatile organic compounds and fine particles, which can penetrate deep into the lungs and trigger or worsen respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and lung cancer.

A 2023 review published in Advances in Respiratory Medicine noted that while the long-term cancer risk from e-cigarette use remains uncertain due to the relatively recent emergence of these products, there is growing evidence of their potential to cause genetic and cellular damage linked to carcinogenesis. The review emphasized that e-cigarettes emit carcinogenic compounds such as formaldehyde, acetaldehyde, and acrolein — some of which are produced when the e-liquid solvents propylene glycol and vegetable glycerin are heated.

Further supporting this, a study from the University of North Carolina found that propylene glycol and vegetable glycerin — the two primary ingredients in most e-liquids — are toxic to lung cells, with toxicity increasing as more flavoring agents and additives are introduced into the e-liquid mixture.

The presence of acrolein, a chemical used as a herbicide and known to cause severe lung irritation, has been specifically highlighted in multiple studies. Acrolein exposure is associated with acute lung injury, asthma exacerbations, and may contribute to the development of COPD and lung cancer over prolonged periods.

Health authorities continue to warn about the dangers of secondhand exposure to e-cigarette emissions. Both the U.S. Surgeon General and the National Academies have stated that inhaling secondhand aerosol from e-cigarettes poses health risks, particularly for children, adolescents, and individuals with preexisting respiratory conditions.

Despite being marketed as a safer alternative to traditional tobacco cigarettes, e-cigarettes are not risk-free. While they generally expose users to fewer toxicants than combustible cigarettes, they are not harmless. The dual threats of metal leaching from devices and chemical toxicity from heated e-liquids underscore the need for stricter regulation of device manufacturing, ingredient transparency, and ongoing surveillance of user health outcomes.

As of April 2026, regulatory bodies such as the U.S. Food and Drug Administration (FDA) have not completed comprehensive systemic reviews of all e-cigarette products currently on the market to determine their full impact on lung health. Experts agree that more longitudinal research is needed to fully understand the long-term consequences of sustained e-cigarette use, particularly among young people who have never smoked traditional cigarettes.

Public health officials continue to recommend that non-smokers, especially youth, avoid initiating e-cigarette use, and that current users consider cessation strategies supported by medical professionals. For individuals seeking to quit nicotine, FDA-approved treatments such as nicotine replacement therapy, prescription medications, and behavioral counseling remain the most rigorously studied and effective options.